Sepsis Clinical Trial
Official title:
Tissue NIRS in the Assessment and Management of Critically Ill Patients
Hypotheses:
1. In the acute phase of early illness, tissue oxygen saturation and vascular occlusion
test (VOT) are important adjuncts in differentiating severe critical illness requiring
ICU admission from patients benefiting from less aggressive therapies (non-ICU
admission).
2. An early feature of severe sepsis is abnormal microcirculatory vasoreactivity.
3. Microvascular reactivity can be measured by means of vascular occlusion test (VOT) using
non-invasive near infrared spectroscopy (NIRS) to measure tissue Oxygen saturation
(StO2).
4. Microvascular reactivity is significantly deranged in patients with early severe sepsis
and is quantifiably different from non-septic critically ill patients.
5. Other measures of microcirculatory perfusion ie. sublingual orthogonal polarization
spectral (OPS) video microscopy, are abnormal and will directionally correlate with VOT
and StO2 in severe sepsis
6. In severely septic patients response to therapy can be assessed by VOT and StO2
monitoring and will correlate with prognosis.
7. A management protocol incorporating VOT and StO2 monitoring in addition to conventional
hemodynamic and biochemical parameters as a guide to therapy will result in improved
outcomes in severely septic patients.
This project will investigate the use of a non-invasive near infrared light (NIR) device in
conjunction with brief arm compression to measure the microcirculation in critically ill
patients. It is know that in patients with overwhelming infections, their blood vessels do
not respond normally and the NIR device can help measure how abnormal their blood vessels
are. This type of testing is non-invasive and can be performed repeatedly without harm to the
patient and may provide an earlier way to determine whether they have overwhelming sepsis and
also may help to optimize the treatments they receive and better tailor their treatments to
the degree of blood vessel abnormalities that are found. If our hypotheses are correct, this
simple non-invasive test could provide a very rapid means of assessing patients that could be
done more safely and quickly than some of the current methods. This would have an important
effect to enhance patient safety and improve outcomes in such critically ill patients.
Project Overview: This project is focused on the early diagnosis and management of septic
shock using tissue near infrared spectroscopy (tNIRS) for continuous and non-invasive
assessment of microcirculatory vasoreactivity as a diagnostic and prognostic indicator in
critically ill patients. A novel aspect of this study is that point of entry of patients will
be via the Critical Care Outreach Team (CCOT) which will ensure patients are assessed in the
early phases of their disease prior to and co-incident with admission to Critical Care Unit
(CCU). The investigators will employ tNIRS to assess peripheral tissue oxygen saturation
(StO2) in all patients assessed by CCOT (n = 1031 patients in 2009) and in addition, the
investigators will employ the NIRS vascular occlusion test (VOT) using a brief episode of
forearm ischemia to quantify microvascular (dys)function.
All patients admitted to CCU via CCOT (n = 230 patients in 2009) will have StO2 monitored and
VOT assessment sequentially throughout the course of their critical illness. Biomarkers to
assess severity of illness, inflammatory processes and microcirculatory reactivity will be
obtained, and in a subset of patients (n = 30), correlations between these parameters and
other indices of microvascular perfusion using sublingual orthogonal polarization spectral
(OPS) imaging videomicroscopy will be sought. As it is estimated that 20-30% of CCOT
admissions are for sepsis (n = 40-60), the inclusion of other critically ill non-septic
patients will enable discrimination of various parameters of VOT to be contrasted between
groups to determine relative diagnostic and prognostic significance.
Statement of Objectives:
1. To assess the diagnostic utility of tNIRS StO2 and VOT in early assessment of critically
ill patients.
2. To determine whether significant and pathognomonic differences exist in StO2 and indices
of VOT between septic patients versus other non-septic critically ill patients and
healthy age matched volunteers.
3. To determine whether correlations exist between biomarkers of inflammation and
vasoreactivity and measures of StO2 and VOT in severely septic patients.
4. To determine whether incorporation of StO2 and VOT into a treatment protocol can
positively impact clinical outcomes in critically ill patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |